Upstate Active Clinical Trials
Study Title:Exploration of Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity Following Various Administration Schedules with CYD Tetravalent Dengue Vaccine, a Phase II, Randomized, Open-Label, Single Center Trial in Adults Aged 18-45 Years in the US.
What is the purpose of the study?To evaluate the safety and immunogenicity of CYD Dengue Vaccine for the military/traveler indication. Dengue Fever is a disease that affects many parts of the developing world as well as parts of the United States.
Upstate Institutional Review Board (IRB) Number:458738
Patient Age Group:Adults
Principal Investigator:Mark E Polhemus, MD
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Blood draws Other: Vital sign assessments, physical exam and medical history
Where will the study take place?505 Irving Avenue, Syracuse, NY 13210 (Institute for Human Performance)
Other Information:Nov 2013 to Oct 2015
Who can I contact for more information?
Name: Gina D Bertolo